Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pancreatic Neoplasms × Radiation × Clear all

Phase

Phase 2 15 Phase 1 6 Phase 1/2 3 Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Glioblastoma 7 Esophageal Neoplasms 7 Uterine Cervical Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Burkitt Lymphoma 6 Breast Neoplasms 6 Rhabdomyosarcoma 5 Esophageal Squamous Cell Carcinoma 4 Urinary Bladder Neoplasms 3 Sarcoma 3 Rectal Neoplasms 3 Medulloblastoma 3 Lymphoma, Follicular 3 Lung Neoplasms 3 Hodgkin Disease 3 Gliosarcoma 3 Brain Neoplasms 3 Vaginal Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Rhabdomyosarcoma, Embryonal 2 Prostate Adenocarcinoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Head and Neck Neoplasms 2

Interventions

Gemcitabine 68 Fluorouracil 28 Oxaliplatin 18 Leucovorin 18 Capecitabine 13 130-nm albumin-bound paclitaxel 12 Irinotecan 9 Albumin-Bound Paclitaxel 9 irinotecan sucrosofate 7 Radiotherapy 6 Taxes 5 Erlotinib Hydrochloride 5 folfirinox 4 rubitecan 3 Surgical Procedures, Operative 3 Specimen Handling 3 Pancreaticojejunostomy 3 Neoadjuvant Therapy 3 Drug Therapy 3 Cisplatin 3 ruxolitinib 2 masitinib 2 dehydroftorafur 2 Saline Solution 2 S 1 (combination) 2 Paclitaxel 2 GV1001 peptide 2 Fentanyl 2 Chemotherapy, Adjuvant 2 Bevacizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06958328 2026-02-02

LAP100

NRG Oncology

Phase 3 Recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡